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1. Introduction 
Bacteria of the Corynebacterineae, a suborder of the Actinobacteria, comprise 
Mycobacterium, Corynebacterium, Nocardia, Rhodococcus and other genera. This suborder of 
high GC gram-positive bacteria includes a number of important human pathogens, such as 
Mycobacterium tuberculosis, Mycobacterium leprae and Corynebacterium diphtheriae, the 
causative agents of tuberculosis, leprosy and diphtheria, respectively. M. tuberculosis is the 
most medically significant species, a devastating human pathogen infecting around one-
third of the entire human population and responsible for more than 1 million deaths 
annually. The Corynebacterineae also includes non-pathogenic species such as 
Mycobacterium smegmatis, a saprophytic species, and Corynebacterium glutamicum, an 
industrial workhorse for the production of amino acids and other useful compounds. These 
relatively fast-growing species serve as useful models to study metabolic processes essential 
to the growth and survival of the slow-growing pathogens. 
All these bacteria share a common feature, a distinctive multilaminate cell wall composed of 
peptidoglycan, complex polysaccharides, and both covalently linked lipids and free 
lipids/lipoglycans (Fig. 1). Among them, mycolic acids are the hallmark of these species. 
These long chain α-branched, β-hydroxylated fatty acids are covalently linked to the 
arabinogalactan polysaccharide layer. This mycolic acid layer is complemented by a 
glycolipid layer to form an outer “mycomembrane” analogous to the outer membrane of 
Gram-negative bacteria. [1, 2]. The outer leaflet of the mycomembrane is composed of a 
variety of lipids including trehalose dimycolates (TDMs), glycopeptidolipids (GPLs), 
phthiocerol dimycocerosates (PDIMs), sulfolipids, phenolic glycolipids (PGLs), and 
lipooligosaccharides. Some of these lipids are widely distributed while others are restricted 
to particular species. For example, TDMs and their structural equivalents are found in both 
mycobacteria and corynebacteria, while PDIMs and PGLs are restricted to a subset of 
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mycobacteria. The structure and hydrophobic properties of the cell wall make it a potent 
permeability barrier that is responsible for intrinsic resistance of mycobacteria to an array of 
host microbiocidal processes, many antibiotics and sterilization conditions [3, 4]. Many of 
the cell wall components of pathogenic mycobacterial species are essential for pathogenesis 
and in vitro growth, hampering efforts to characterize the function of individual proteins in 
their assembly. In contrast, some non-pathogenic species such as C. glutamicum can tolerate 
the loss of major cell wall components, making them useful model systems for delineating 
processes involved in the assembly of core cell wall structures. 
 
Figure 1. Mycobacterial plasma membrane and cell wall with flow of key metabolic pathways. Some 
of the metabolites are exported to the mycomembrane. SLD, small lipid droplet; LD, lipid droplet; FA-
CoA, fatty acyl-CoA. See text for other abbreviations used in the figure.  
Studies on mycobacteria and corynebacteria provide a unique opportunity to illustrate the 
complexity and diversity of lipid metabolic pathways in bacteria. They have a significantly 
higher lipid content than other bacteria with cell wall lipids comprising ~40% of the dry cell 
mass. M. tuberculosis produces a diversity of lipids unparalleled in bacteria, from simple 
fatty acids to highly complex long chain structures such as mycolic acids. It has devoted a 
significant proportion of its coding capacity to lipid metabolism and produces about 250 
enzymes dedicated to fatty acid metabolism, which is around five times the number 
produced by Escherichia coli [5]. Lipid biosynthesis places a significant metabolic burden on 
the organism but is ultimately advantageous, allowing M. tuberculosis to survive and 
replicate in the inhospitable environment of host macrophages. While capable of de novo 
synthesis, these bacteria also scavenge and degrade host cell membrane lipids to acetyl-
CoA, via broad families of β-oxidation and other catabolic enzymes, for incorporation into 
their own metabolic pathways and to fuel cellular processes.  
The plasma membrane provides the platform for lipid metabolism. While some lipid 
metabolic reactions take place in the cytoplasm or cell wall, the plasma membrane is the 
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pivotal site for the metabolism of lipids. At the same time, this membrane must perform 
many other functions associated with energy production, nutrient uptake, protein export, 
and various sensing/signaling reactions. Studies on how these metabolic and cellular 
processes might be organized within bacterial plasma membranes are in their infancy. 
Understanding the homeostasis of the plasma membrane is particularly important in 
Corynebacterineae organisms because this structure must support the high biosynthetic 
demands of sustaining such a lipid-rich cell wall. In this chapter, we focus our discussion on 
processes of lipid metabolism that are critical for the biogenesis and maintenance of the 
plasma membrane, and illustrate the recent progress on our understanding of plasma 
membrane biogenesis in mycobacteria and corynebacteria. 
2. Functions of plasma membrane lipids in mycobacteria and 
corynebacteria 
In this section we will describe the functions of plasma membrane lipids. First, we will 
describe the functions of major structural phospholipids. We will then describe quantitatively 
minor lipids, which have important metabolic/physiological functions. Lastly, we will discuss 
the functions of neutral lipids because their biosynthesis is closely linked to phospholipid 
metabolism and neutral lipid storage is a critical part of plasma membrane homeostasis.  
2.1. Structural lipids 
Major structural components of the mycobacterial plasma membrane are phospholipids 
such as cardiolipin (CL), phosphatidylethanolamine (PE), phosphatidylinositol (PI), and 
glycosylated PIs (i.e. phosphatidylinositol mannosides (PIM), lipomannans (LM) and 
lipoarabinomannans (LAM), see below). The ratio of these phospholipids may vary 
depending on the species and growth conditions [6-8]. For example, one study indicated 
that CL, PE, and PI/PIMs represent about 37, 32, and 28%, respectively, of the total 
phospholipids in the plasma membrane in M. smegmatis [9], while another reported the ratio 
in Mycobacterium phlei to be about 50, 10, and 40% [10]. Phosphatidylglycerol (PG), which is 
abundant in other bacteria, is a relatively minor species in mycobacteria. Deletion of the PI 
biosynthetic gene has been shown to be lethal in M. smegmatis [9], indicating that PI or 
glycosylated PIs are essential for mycobacterial viability. In M. tuberculosis, putative PI 
synthetase (Rv2612c) and PGP synthetase (Rv2746c, involved in CL synthesis) genes are 
predicted to be essential [11], while the PS synthetase gene (Rv0436c, involved in PE 
synthesis) is not [12]. In corynebacteria, major species of phospholipids are PI, PG, CL, and 
acylphosphatidylglycerol (APG) [13], and PE appears to be absent.  
CL is widely found in both prokaryotes and eukaryotes. It forms aggregates within the 
membrane bilayer. Nonyl acridine orange (NAO) is a fluorescent dye which is proposed to 
bind the hydrophobic surface created by the CL cluster [14], allowing microscopic 
visualization of CL domains. Indeed, using NAO, CLs were found to be enriched in septa 
and poles of actively dividing M. tuberculosis and M. smegmatis cells [15, 16]. CL has a non-
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bilayer structure [17, 18], and carries a small partially immobilized head group that is more 
exposed to the aqueous environment than those of other glycerophospholipids [19]. 
Although the physiological function of CL is unclear, its physical properties may indicate 
that it provides a platform for membrane-protein interactions. Indeed, some mycobacterial 
enzymes require CL for activity [20-22], although the molecular basis for these observations 
has not been clarified. Recent fractionation studies in C. glutamicum revealed that CL (as well 
as other phospholipids) is enriched in the plasma membrane [23, 24]. However, a large 
proportion of CL is also found to be associated with the outer membrane [24], suggesting 
that some of these phospholipids are exported to the outer membrane in corynebacteria. 
Similarly, CL is released from M. bovis bacillus Calmette-Guerin residing in host 
phagosomes, and converted to lyso-CL by a host phospholipase A2 [25]. It has been 
suggested that lyso-CL may influence host immune responses during infection. 
PE is another major class of glycerophospholipids in mycobacteria. Although PE is generally 
found in all organisms, it is particularly abundant in bacterial plasma membranes [26]. 
Mycobacteria are no exception [20], but corynebacteria apparently lack the capacity to 
synthesize PE [27]. Indeed, PE biosynthetic enzymes, such as PS synthetase and PS 
decarboxylase, appear to be absent in corynebacterial genomes. Corynebacterium aquaticum 
has been reported to possess PE [28], but this species was later reclassified as Leifsonia 
aquatica [29], which belongs to the suborder Micrococcineae of the order Actinomycetales. 
The functions of PE remain elusive at the molecular level, but it appears to play important 
roles as a component of the plasma membrane. For example, TBsmr, a small multidrug 
resistance family protein from M. tuberculosis, shows enhanced catalytic activities when PE 
is supplemented in a reconstituted liposome [30].  
PIs are an important class of phospholipids, and are known to be further modified by 
extensive glycosylation. The resultant lipoglycans, termed PIMs, LM, and LAM, are 
essential structural components of mycobacterial and corynebacterial cell walls. 
Furthermore, in pathogenic species, they have been suggested to perform additional roles in 
the modulation of host immune responses in favor of the pathogen through myriad effects 
on macrophages including cytokine production, inhibition of phagosome maturation and 
apoptosis [31-34]. PIMs are oligo-mannosylated PIs carrying up to 6 mannose residues while 
LM/LAM carry much longer mannose polymers with arabinan modifications. It remains 
controversial if these glycolipids are embedded in the plasma membrane or exported to the 
outer membrane. A recent study suggests that LM/LAM appear to be anchored to both the 
plasma membrane and outer membrane [35]. In C. glutamicum, the outer membrane and 
plasma membrane were fractionated on sucrose gradients upon cell lysis, and the analysis of 
these membrane sub-fractions demonstrated that PIMs, LM and LAM are all enriched in the 
plasma membrane fraction [23]. Another recent study also suggested that PI/PIMs are major 
components of the plasma membrane of C. glutamicum [24]. In the latter study, however, 
substantial amounts of PI/PIMs were detected in the outer membrane as well. The functional 
significance of these subcellular localizations, as well as the physiological roles of LM/LAM 
in each of these locations, remain important questions. The structural importance of PIMs 
remains unclear as well. For example, a pimE-deletion mutant that cannot produce mature 
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PIM6 species (see below) is viable, but shows severe plasma membrane abnormalities [36], 
suggesting that higher order PIMs may be involved in the maintenance of plasma 
membrane integrity.  
It is notable that some unusual phospholipids have been identified in corynebacteria. APG 
is an acylated form of PG which is widespread in corynebacteria [37-40], and is a major 
phospholipid species in Corynebacterium amycolatum. Another interesting phospholipid from 
C. amycolatum is acyl-phosphatidylinositol (API), which was identified by electrospray 
ionization mass spectroscopy [41]. C. amycolatum lacks a mycolic acid-based outer 
membrane, and does not appear to have a fracture plane other than the plasma membrane 
[42]. Therefore, APG and API are likely to be components of the plasma membrane, and are 
suggested to play structural roles. Very little is known about their biosynthesis, and 
acyltransferases responsible for their synthesis remain to be identified for both lipid species.  
2.2. Functional lipids 
There are some examples of lipids that appear to play no structural roles in the plasma 
membrane. They often exist in low quantities but play important functional roles. Among 
these, polyprenol-phospho-sugars function as sugar donors. Two well-studied examples are 
polyprenol phosphomannose (PPM) and decaprenol phosphoarabinose (DPA). These 
molecules are the donors of mannose and arabinose, respectively, and their biosynthesis will 
be discussed in a later section.  
PI 3-phosphate, recently identified in both M. smegmatis and C. glutamicum [43], may prove 
to be another interesting example of a functional lipid. It accumulates only transiently upon 
stimulation by high concentrations of salt, and behaves as if it is involved in a signaling 
cascade. However, whether PI 3-phosphate represents a mediator of stress responses 
remains to be addressed. More recently, lysinylated PG was identified as a minor 
phospholipid species in M. tuberculosis [44]. The synthesis of lysinylated PG is mediated by 
LysX and a lysX deletion mutant showed altered phospholipid metabolism and membrane 
integrity [16, 44], suggesting a regulatory role of lysinylated PG in plasma membrane 
homeostasis.  
Carotenoids are photo-protective pigments and serve to scavenge free radicals or harvest 
light [45]. Several mycobacterial species are known to produce carotenoids with the notable 
exception of M. tuberculosis, despite the presence of a carotenoid oxidase in the human 
pathogen [46]. These hydrophobic pigments are thought to be present in the plasma 
membrane but whether they play structural roles in addition to a photo-protective role 
remains to be elucidated. 
2.3. Lipid storage for energy and carbon 
Neutral lipids are an important reservoir of stored energy and carbon, and their metabolism 
is closely linked to plasma membrane phospholipid metabolism. Unlike many other bacteria 
which use polyhydroxyalkanoates as a lipid storage material [47], Actinobacteria use 
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triacylglycerides (TAGs) as a major form of lipid storage, and the presence of TAGs has been 
reported in Mycobacterium, Streptomyces, Rhodococcus and Nocardia [48-52]. Interestingly, 
corynebacteria seem to lack the capacity to synthesize TAG, indicating that some lineages of 
Actinobacteria have eliminated this capacity at some point in their evolution. Recent 
evidence suggests that M. tuberculosis accumulates TAG-based lipid droplets while residing 
in macrophages using fatty acids released from host TAGs, and this process is critical for 
acquiring a dormancy phenotype [53]. Nevertheless, a mutant defective in accumulating 
TAG remained viable under in vitro dormancy-inducing conditions [54]. These somewhat 
contradictory observations suggest that our understanding of TAG metabolism in 
mycobacteria is far from complete. As we illustrate later, there appear to be several 
redundant genes involved in the final step of TAG synthesis, suggesting that it is an 
important regulatory step of lipid metabolism in these bacteria.  
Cholesterol has recently been suggested to be an alternative form of lipid storage in 
mycobacteria. Neither mycobacteria nor corynebacteria have the capacity to synthesize 
cholesterol. However, cholesterol is taken up by M. tuberculosis cells residing in the host, and 
components of the mce4 operon have been shown to be involved in cholesterol import [55]. 
Cholesterol catabolism is critical in the chronic phase of animal infection, and a fully 
functional catabolic pathway is encoded by the M. tuberculosis genome [56]. Furthermore, 
cholesterol appears to accumulate in the mycobacterial cell envelope, and this might 
represent a potential form of lipid storage for M. tuberculosis during animal infection [57, 58]. 
Although the authors of this study suggested that cholesterol accumulates in the outer 
membrane, it remains possible that the plasma membrane is the true site of accumulation. 
Therefore, in addition to acting as a lipid storage molecule, cholesterol may play roles in 
plasma membrane structure and function, and these possibilities await further exploration. 
Catabolism of cholesterol, amino acids and odd-chain-length/methyl branched fatty acids 
produces propionyl-coenzyme A (CoA). Propionate accumulation has been shown to be 
toxic in various organisms [59-61], and M. tuberculosis has multiple pathways to metabolize 
propionyl-CoA [62]. Metabolized propionyl-CoA is in part incorporated into TAG [63], and 
it has been suggested that TAG functions as a sink for reducing equivalents in addition to 
being a source of carbon and energy.  
3. Structure and metabolism of plasma membrane lipids in mycobacteria 
and corynebacteria 
In this section, we will describe the structure and metabolism of various lipids found in the 
plasma membrane of mycobacteria and corynebacteria in more detail. Lipids are categorized 
into the following four classes based on their key structural features.  
3.1. Fatty acids 
M. tuberculosis devotes a large proportion of its coding capacity to genes involved in fatty 
acid metabolism [5], highlighting the importance of lipids to the organism. Fatty acid 
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metabolism is essential for intracellular survival of the pathogen since it forms the 
precursors of key membrane components such as plasma membrane phospholipids and 
outer membrane glycolipids. In particular, mycolic acids, which are very long chain α-alkyl 
β-hydroxy fatty acids, form the hydrophobic, protective mycomembrane described earlier. 
M. tuberculosis encodes two distinct enzyme systems for biosynthesis of fatty acids, 
designated FAS (fatty acid synthase) I and II (Fig. 2). Studies on fatty acid synthesis date 
back to the 1970s when M. smegmatis was shown to contain both type I fatty acid synthetase 
(FAS-I), involving a large multifunctional polypeptide, and type II fatty acid synthetase 
(FAS-II), consisting of a series of distinct enzymes [64]. The key elongation unit is malonyl-
CoA, which is produced by acetyl-CoA carboxylase (ACCase) and the M. tuberculosis 
genome encodes several such enzymes (AccA1-3 and AccD1-6). The resultant malonyl-CoA 
is incorporated into fatty acids by the two FAS systems.  
 
Figure 2. Fatty acid biosynthesis pathways in mycobacteria. Point of inhibition by the front-line 
tuberculosis drug isoniazid is indicated. Product profile of FAS-I is bimodal, and C16-C18-CoA and C24-
C26-CoA are produced. Dashed lines indicate that some of the fatty acid products are further utilized for 
mycolic acid production.  
3.1.1. De novo synthesis by FAS-I 
Surprisingly, members of the Corynebacterineae use a eukaryote-like FAS-I system for de 
novo fatty acid synthesis. The single, essential [11], 9.2kb fas gene encodes a 326 kDa protein 
containing all seven domains necessary to perform the iterative series of reactions: acyl 
transferase, enoyl reductase, β-hydroxyacyl dehydratase, malonyl transferase, acyl carrier 
protein, β-ketoacyl reductase, and β-ketoacyl synthase [65, 66]. This very large protein 
elongates acetyl groups by 2-carbon (acetate) units using acetyl-CoA and malonyl-CoA. 
Early rounds of elongation yield C16 to C18-CoA products that are used for synthesis of 
membrane phospholipids or to feed into the FAS-II system. More extensive elongation 
yields C24-C26 products that ultimately form the α-branch of mycolic acids. Unlike M. 
tuberculosis, C. glutamicum encodes two fas genes (fasA and fasB) with FasA taking the 
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dominant role [67]. The presence of two Fas proteins may compensate for the lack of a FAS-
II system in this organism. 
3.1.2. Elongation by FAS-II 
The FAS-II system is commonly found in bacteria and plants and, unlike FAS-I, is composed 
of a series of separate enzymes, each performing one step in the pathway. FAS-II elongates 
medium chain fatty acids derived from FAS-I using malonyl-CoA, producing C18-C30 fatty 
acids [68]. FAS-II has been extensively studied in E. coli [69] and orthologs of the fab genes 
have been identified in mycobacteria. AcpM is a mycobacterial acyl carrier protein (ACP) 
and plays a key role in transferring acyl groups between the various enzyme components 
[70]. The seven genes are located in two clusters on the M. tuberculosis chromosome [5], 
comprising mtfabD-acpM-kasA-kasB-accD6 and mabA-inhA. Initially, the malonate group is 
transferred from malonyl-CoA to AcpM by the MtFabD protein. Then MtFabH performs a 
Claisen condensation of malonyl-ACP with acyl-CoA to form β–ketoacyl-ACP. A four-step 
cycle is then initiated [64] in which: 
1. β–ketoacyl-ACP reductase MabA reduces the β–keto group with concomitant oxidation 
of NADPH 
2. β-hydroxyacyl-ACP dehydratase dehydrates the β-hydroxyl to enoyl-ACP 
3. enoyl-ACP reductase InhA, a target of the first-line anti-tuberculosis drug isoniazid 
(INH) [71], reduces enoyl-ACP to acyl-ACP with concomitant oxidation of NADPH 
4. β-ketoacyl-ACP synthase KasA/B elongates acyl-ACP by 2 carbon units, forming β-
ketoacyl-ACP, which can feed back into step 1.  
In this way, the hydrocarbon chain increases by 2 carbons each cycle. Further elongation and 
processing of the products of FAS-II produces the precursors of the long meromycolate 
chains that are condensed with the α-branches derived from FAS-I by the large polyketide 
synthase Pks13 [72]. Reduction of the β–keto group by CmrA forms the mature C60-C90 
mycolic acid [73]. 
3.2. Glycerolipids 
Glycerolipids include both nonpolar lipids and polar phospholipids. Their biosynthesis is 
overlapping and 1,2-diacyl-sn-glycerol 3-phosphate, commonly known as phosphatidic acid 
(PA), is an important intermediate at the branch point (Fig. 3) [74]. In this section, we focus 
our discussion on the biosynthesis of PA and its conversion to non-polar lipids. Non-polar 
lipids are generally divided into three different classes depending on the number of fatty 
acids attached to glycerol: monoacylglycerol (MAG), diacylglycerol (DAG) and TAG. TAG 
is a glycerol carrying three fatty acyl chains, and its biosynthesis diverges from 
phospholipid synthesis after the synthesis of PA. TAG is a major component of lipid 
droplets, which accumulate in the cytoplasm. How TAG is made in the plasma membrane 
and incorporated into lipid droplets remains largely unclear. Here, we provide an overview 
of the TAG metabolic pathway. 
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Figure 3. Glycerolipid/phospholipid biosynthesis pathways. Some pathways such as TAG and PE 
biosynthesis (shown as green arrows) do not occur in corynebacteria while some others (shown as blue 
arrows) are known to occur only in corynebacteria. PG is abundant in corynebacteria, but is a minor 
species in mycobacteria.  
3.2.1. Biosynthesis of PA 
The first step of PA biosynthesis is mediated by glycerol phosphate acyltransferase (GPAT) 
transferring an acyl chain from acyl-CoA to glycerol-3-phosphate, forming acyl-glycerol 3-
phosphate. In general, this reaction produces 1-acyl-sn-glycerol 3-phosphate. However, 
mycobacteria are unusual in that 2-acyl-sn-glycerol 3-phosphate is used as the main 
intermediate for the production of PA [75]. Another unusual feature is that oleic acid, an 
unsaturated fatty acid often found at the sn-2 positions of glycerolipids, is found at the sn-1 
position in mycobacteria. Instead, palmitic acid, a saturated fatty acid, is the preferred fatty 
acid attached to the sn-2 position in mycobacteria [75, 76]. In the second step, acylglycerol 
phosphate acyltransferase (AGPAT) further transfers a fatty acid from acyl-CoA to 2-acyl-
sn-glycerol 3-phosphate, producing PA. PA can be diverted to TAG synthesis, or activated 
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to form cytidine diphosphate-diacylglycerol (CDP-DAG), which is the precursor for the 
synthesis of phospholipids. Therefore, PA represents an important branch point for the 
synthesis of TAG and phospholipids [74]. An alternative pathway for PA synthesis is 
phosphorylation of DAG by DAG kinase, and Rv2252 has been suggested to be involved in 
this reaction [77]. Disruption of this enzyme results in altered PIM biosynthesis, but precise 
functions of this metabolic pathway remain unclear.   
3.2.2. TAG Biosynthesis 
TAG is de novo synthesized by two steps. First, PA is dephosphorylated to become DAG, 
and this reaction is mediated by phosphatidic acid phosphatase (PAP). PAP was discovered 
from animal tissues in 1957 by the group of Eugene Kennedy [78], and the gene encoding 
this activity was recently identified in Saccharomyces cerevisiae [79]. Nothing is known about 
this enzyme in mycobacteria or corynebacteria. In the second step, diacylglycerol 
acyltransferase (DGAT) catalyzes the addition of a fatty acyl-CoA to DAG to form TAG. 
Until recently, little was known about the genes involved in this final step of TAG synthesis 
in mycobacteria. Analysis of this final step is complicated because there are multiple genes 
encoding TAG synthetase in mycobacteria and corynebacteria. For example, the M. 
tuberculosis genome encodes 15 putative TAG synthetase genes [48, 80]. Despite the 
redundancies, recent studies reported that some of these tgs genes are critical for TAG 
synthesis in M. tuberculosis [48, 54]. Specifically, TAG synthetases encoded by Rv3130c (tgs1), 
Rv3734c (tgs2), Rv3234c (tgs3), and Rv3088 (tgs4) have been shown to have TAG synthetase 
activities [53]. Furthermore, Tgs1 has been demonstrated to be the main contributor to TAG 
synthesis and lipid droplet formation in M. tuberculosis [53]. More recently, Ag85A, which is 
known as a mycolyltransferase involved in TDM biosynthesis, was shown to possess DGAT 
activity [81]. Ag85A is not homologous to other tgs genes, and may represent a novel class of 
TAG biosynthetic enzymes. TAG not only forms a lipid droplet in the cytoplasm, but also 
accumulates in the cell wall of mycobacteria [82]. Therefore, Ag85A located in the cell wall 
might be involved in the production of surface-exposed TAGs.  
3.2.3. Utilization of TAG 
Under starvation conditions where stored TAG needs to be mobilized for energy 
production, TAG is catabolized by lipases. In 1977, TAG lipase was purified from 
stationary phase M. phlei and predicted to have a molecular weight of about 40 kDa [83]. 
More recently, LipY, encoded by the M. tuberculosis Rv3097c gene, was identified as a TAG 
lipase [84]. LipY appears to play a critical role in TAG catabolism because a M. tuberculosis 
lipY deletion mutant cannot utilize accumulated TAG under starvation conditions. 
Another recent study demonstrated that LipY has a dual localization pattern [85]: while a 
fraction of LipY was found in the cytoplasm, consistent with its role in the catabolism of 
intracellular TAG, a significant fraction of LipY was also localized to the outer membrane 
of the cell wall, indicating that it may be involved in the breakdown of exogenously 
available TAGs. Indeed, it has been long known that M. tuberculosis depends on fatty 
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acids as a preferred energy source during infection [86], and LipY may well be a critical 
enzyme for the utilization of host lipids during an M. tuberculosis infection. Another lipase 
encoded by Rv0183 shows preference for MAG over DAG and TAG, and is localized to 
the cell wall [87], suggesting its involvement in subsequent reactions of TAG breakdown. 
However, whether it is involved in degradation of host-derived TAG or intracellular TAG 
remains to be determined.  
3.2.4. Lipid droplet formation 
In eukaryotes, lipid droplets form in between the two leaflets of the endoplasmic reticulum 
membrane [88]. In bacteria, a distinct mechanism of lipid body formation has been 
proposed. For example, in rhodococci, TAG is formed in the cytoplasmic surface of the 
plasma membrane. Small lipid droplets are then fused to each other, coated by a monolayer 
of phospholipids, and released from the surface of the plasma membrane into the cytoplasm 
as mature lipid droplets [89]. Although no endogenous proteins have been found to 
associate with lipid droplets in rhodococci or mycobacteria, heterologous expression of 
known lipid droplet-associated proteins resulted in correct targeting of these proteins to 
lipid droplets in both R. opacus and M. smegmatis [90, 91], allowing visualization of lipid 
droplets in these organisms.  
3.3. Phospholipids 
3.3.1. CDP-DAG 
In both eukaryotic and prokaryotic cells, PA is activated by CTP to form CDP-DAG, and this 
reaction is mediated by CDP-DAG synthase [92]. The synthesis of CDP-DAG commits the 
pathway to phospholipid biosynthesis, and CDP-DAG is a common precursor for the 
biosynthesis of all glycerophospholipids in mycobacteria and corynebacteria. The activity of 
CDP-DAG synthetase is associated with plasma membrane in M. smegmatis, and is possibly 
encoded by the cdsA (Rv2881c) gene in M. tuberculosis H37Rv [93]. 
3.3.2. CL 
CL is composed of four acyl chains, three glycerols and two phosphates, and is structured in 
a 1,3-diphosphatidylglycerol configuration [94]. It is a common phospholipid in bacteria, 
and is one of the abundant phospholipids in mycobacteria and corynebacteria. To initiate 
CL synthesis, PG phosphate synthase first produces PG phosphate (PGP) using CDP-DAG 
and glycerol 3-phosphate as substrates. An M. smegmatis strain engineered to overexpress 
M. tuberculosis PgsA3 (encoded by Rv2746c) was shown to overproduce PG, suggesting that 
PgsA3 is the PGP synthase [9]. PGP is then converted into PG via PGP phosphatase. Three 
phosphatases, PgpA, PgpB, and PgpC, have been identified as PGP phosphatases in E. coli 
[95-97]. Furthermore, Gep4 and PTPMT1 have been identified as PGP phosphatases in yeast 
and mammals, respectively [98, 99]. Some homologs exist in the genomes of mycobacteria 
and corynebacteria, but experimental verification of these genes remains to be performed. 
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Typically, the final step of CL synthesis in prokaryotes is mediated by a reaction that utilizes 
two PG molecules, producing one molecule of CL and one molecule of glycerol. However, 
in mycobacteria, the eukaryote-like reaction, which utilizes PG and CDP-DAG to produce 
CL, has been shown to occur [100], and Jackson and colleagues have suggested that PgsA2 
might be the enzyme responsible for this reaction [9].  
3.3.3. PE 
The precise structure of PE was recently reported as 1-O-tuberculostearoyl-2-O-palmitoyl-
sn-glycero-3-phosphoethanolamine in M. tuberculosis using tandem mass spectrometry [101]. 
In the initial step of PE synthesis, PS synthetase transfers serine to CDP-DAG and produces 
PS. In the second step, PE is produced by decarboxylation of PS mediated by PS 
decarboxylase. Genes encoding putative PS synthetase (pssA, Rv0436c) and PS 
decarboxylase (psd, Rv0437c) are found in tandem in the M. tuberculosis genome [9]. 
However, there is no experimental evidence demonstrating the identities of the genes. In M. 
smegmatis, PS synthetase and PS decarboxylase activities are enriched in different membrane 
fractions, which can be distinguished by sucrose gradient sedimentation [102]. However, the 
significance of differential membrane localization remains to be clarified.  
3.3.4. PI 
PI is a major phospholipid in both mycobacteria and corynebacteria and forms the anchor 
for the PIMs, which are substrates for heavy mannosylation to form LMs and additional 
arabinosylation to produce LAMs. PI is formed by the PI synthase PgsA (Rv2612c) from 
CDP-DAG and myo-inositol [9, 103]. Inositol is not a common metabolite in bacteria. It is 
therefore surprising that mycobacteria produce copious amounts of inositol through 
pathways shared with eukaryotes for incorporation into a range of metabolic pathways 
(recently reviewed in [104]). The enzyme D-myo-inositol 3-phosphate synthase (Ino1) 
converts glucose-6-phosphate to D-myo-inositol 3-phosphate, which is dephosphorylated by 
one of several inositol monophosphatases to produce myo-inositol [105].  
3.3.5. PIMs 
All Corynebacterineae synthesize PIMs that are important components of the cell envelope. 
Polar PIM species can also serve as membrane anchors for LM and LAM. Many of the steps 
of PIM/LM/LAM biosynthesis have now been elucidated [106]. Extensive genetic and 
biochemical studies have demonstrated that the synthesis of PIMs occurs linearly in 
mycobacteria with PI as the starting substrate (reviewed in [107]) (Fig. 4A). Early steps of the 
pathway occur on the cytoplasmic face of the plasma membrane. A PIM biosynthetic 
membrane, enriched in the early steps, has been purified by sucrose gradient fractionation 
as a membrane subdomain termed PMf, which is distinct from the bulk plasma membrane 
[102]. Mannosyltransferases performing the early steps utilize the water-soluble mannose 
donor, GDP-Man, which can be produced from exogenously acquired mannose or via de 
novo synthesis from the glycolytic pathway when fructose-6-phosphate is transformed by 
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the enzymes ManA (Rv3255c), ManB (Rv3257c) and ManC (Rv3264c) [108-111], with a 
degree of redundancy reported at the ManC (NCgl0710) step in C. glutamicum [112]. The 
first step of PIM synthesis involves mannosylation of the C2-position of the inositol ring of 
PI by the enzyme PimA (Rv2610c) to form PIM1 [113, 114]. PimA is an essential enzyme in 
mycobacteria [11, 113] and absent in humans, making it a current target for drug 
development by several groups. The crystal structure of PimA from M. smegmatis has been 
solved in complex with GDP and GDP-Man at resolutions of 2.4Å and 2.6Å, respectively 
[115, 116]. PimA has a typical GT-B fold of glycosyltransferases consisting of two Rossmann-
fold domains with a deep fissure at the interface, which contains the active site. Close to the 
GDP-Man binding site, the N-terminal domain displays a deep pocket containing highly 
conserved hydrophobic residues. This pocket is proposed to bind the acyl moieties of the 
acceptor substrate PI [116].  
Next, O-6 mannosylation of the myo-inositol ring is performed by the cytoplasmic α-
mannosyltransferase PimB’ (Rv2188c) [117, 118] resulting in the formation of PIM2. While 
the mycobacterial enzyme Rv0557 was originally assigned this function [119], later studies 
showed that Rv2188c was the true PimB (designated PimB’) [118], with Rv0557 being 
renamed MgtA and included in the LM-B pathway [120, 121] (see below). PimB’ is an 
essential enzyme in mycobacteria [11, 117] and the crystal structure of the equivalent 
corynebacterial enzyme has been solved at high resolution complexed with nucleotide [122]. 
In corynebacteria, PIM2 is detected mainly in its mono-acylated form, but in mycobacteria 
PIM2 accumulates in the cell envelope as monoacyl (AcPIM2) and diacyl (Ac2PIM2) forms, 
the former produced by the acyltransferase Rv2611c [123] which acts optimally on the 
product of the PimB’ reaction [117].  
The next enzyme in the pathway, PimC, has been identified in M. tuberculosis strain 
CDC1551 and could produce trimannosylated PIMs [124]. However, the absence of this 
enzyme in other strains indicates redundancy at this step and the enzymes involved remain 
to be identified, as does the putative “PimD” protein. Flipping of PIM intermediates from 
the cytoplasmic face of the membrane to the periplasm is thought to occur at this point of 
the pathway, but the precise intermediate and transporter involved are also undefined.  
AcPIM4 species can be further mannosylated to form more polar PIMs in reactions thought 
to take place on the periplasmic side of the cytoplasmic membrane. These reactions are 
performed by glycosyltransferases that require a lipid sugar donor in the form of PPM, since 
these reactions are amphomycin-sensitive [36, 125-128]. In mycobacteria, AcPIM4 is 
proposed to be a branch point for synthesis of polar PIM end products and LM/LAM. PimE 
(Rv1159) has been shown to elongate AcPIM4 with one or more α1-2 linked mannoses to 
form AcPIM6 [36]. This polytopic membrane protein has sequence similarities with 
eukaryotic PIG-M mannosyltransferases and localizes to a cell wall-associated plasma 
membrane subdomain in M. smegmatis, termed PM-CW, to which enzymatic activities of 
AcPIM4-6 synthesis are enriched [102]. Its catalytic activity was successfully mapped to a 
conserved aspartate residue in the first outer loop of the protein. Whether PimE also forms 
AcPIM6 is unknown. Interestingly, no PimE orthologue is present in C. glutamicum and 
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Ac/Ac2PIM6 do not accumulate in this species, so the formation of Ac/Ac2PIM5/6 appears to 
be a mycobacterium-specific side-branch of the pathway. 
Surprisingly, studies in M. smegmatis have revealed a role for a lipoprotein in PIM/LAM 
synthesis, since lpqW mutants produce reduced levels of LM/LAM [129]. As the only non- 
enzymatic component of the pathway identified to date, LpqW has been proposed to have 
a regulatory role at the bifurcation point of the pathways, as well as a functional 
connection with PimE, since mutations in the pimE gene can bypass the requirement for 
LpqW [130]. Very recent studies have implicated the corynebacterial ortholog of LpqW in 
the LM-B pathway as well (Rainczuk et al, submitted). Structural studies on the M. 
smegmatis LpqW revealed a scaffold similar to substrate binding proteins associated with 
ABC transporters, which has evolved to fulfill a new role in the regulation of PIM/LAM 
biosynthesis [131]. 
3.3.6. LM/LAM 
A subpopulation of PIMs (AcPIM4 in mycobacteria [128, 129, 132] and AcPIM2 in 
corynebacteria [133]) can be extended with chains of α1-6 linked mannose to form LM that is 
further modified with a number of single α1-2 mannose side chains [134-136]. MptB is a 
PPM-dependent mannosyltransferase involved in extending AcPIM2 to form the proximal 
α1-6 mannan backbone of LM in C. glutamicum but is redundant in M. smegmatis [133], 
indicating additional complexity at this step in mycobacteria. Further elongation is 
performed by MptA (Rv2174) [135, 136], with MptC (Rv2181) required for addition of α1-2 
linked Man side chains [106, 134, 137, 138]. Further additions of arabinose units by EmbC 
(Rv3793), AftC (Rv2673), AftD (Rv0236c) and at present unidentified α1-5 
arabinofuranosyltransferases, result in the formation of mature LAM [139-142]. In M. 
tuberculosis and other pathogenic mycobacteria, additional mannose capping is present 
[143], synthesized by the enzymes MptC [137] and Rv1635c [144]. Alternatively, M. 
smegmatis LAM is capped with inositol phosphate [145]. 
While the general PIPIMLMLAM pathway is conserved in corynebacteria, a second 
pathway of lipoglycan biosynthesis exists in which a sub-population of LM lipoglycans is 
assembled on a glucopyranosyluronic acid diacylglycerol (Gl-A, GlcADAG) glycolipid 
anchor [118, 121, 133]. In this pathway (Fig. 4B), Gl-A is first mannosylated by MgtA 
(NCgl0452 in C. glutamicum and previously termed PimB, see above) forming mannosyl-
glucuronic acid diacylglycerol (Gl-X, ManGlcADAG), which is subjected to further α1-6 
(backbone) and α1-2 (side unit) mannosylation resulting in LM [121]. This pathway shares 
some PPM-dependent enzymes with the PI-based LM pathway including MptB, since an 
mptB (NCgl1505) mutant of C. glutamicum fails to produce intermediates beyond Gl-X or 
AcPIM2 [133]. For clarity, the PI-based LM pool has been designated LM-A while this 
second pathway produces LM-B [121, 146], the major LM pool in C. glutamicum [118]. While 
C. glutamicum produces LAMs via LM-A using a similar pathway to mycobacteria, its LAMs 
are smaller and structurally distinct, with more extensive mannosylation and singular Araf 
capping [147]. 
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Figure 4. Summary of Lipoglycan Biosynthesis Pathways in Corynebacterineae. A) The 
mycobacterial pathway and structures for LM-A/LAM are shown, although several steps are inferred 
from studies in C. glutamicum. A progression from PIM1 to AcPIM2 via AcPIM1 can also occur but is 
sub-optimal in mycobacteria. AcPIM3 is shown as the substrate for the unidentified flippase but 
AcPIM2 may be the preferred substrate: AcPIM2 appears to be the flipped intermediate in C. 
glutamicum. Reactions associated with the PMf and PM-CW subfractions of M. smegmatis are shaded 
orange and grey, respectively. B) LM-B pathway in C. glutamicum. Its presence in mycobacteria remains 
to be determined. Intermediates representing Gl-Y and Gl-Z have been detected in very recent studies 
(Rainczuk et al, submitted). C) PPM serves as the lipid-linked donor of mannose for both pathways. The 
mechanism of flipping is undetermined. PM, plasma membrane. Other abbreviations are as defined in 
the text. 
3.4. Prenol lipids 
Polyprenol phosphate (Pol-P) is a key carrier lipid in synthesis of the core structures of the 
mycobacterial cell wall, including peptidoglycan and arabinogalactan. Unlike most bacteria, 
mycobacteria contain multiple types of Pol-P. For example, M. smegmatis produces 
decaprenol phosphate (C50, Dec-P, [148]) and heptaprenol phosphate (C35, Hep-P, [149]). 
Polyprenols are thought to be synthesized via the condensation of two C5 lipids, isopentenyl 
diphosphate [150-152] and dimethylallyl diphosphate derived from the mevalonate-
independent methylerythritol 4-phosphate (MEP) pathway. These reactions are catalyzed by 
prenol diphosphate synthases and two M. tuberculosis proteins, Rv2361c and Rv1086, acting 
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sequentially, are thought to fulfill this role [148, 149, 153-155].  Finally, the C50 decaprenol 
diphosphate is dephosphorylated to produce Dec-P by an unknown phosphatase. 
3.4.1. Polyprenol-phospho-sugars 
3.4.1.1. PPM 
PPM, a β-D-mannosyl-1-monophosphoryldecaprenol, is utilized by periplasmic 
mannosyltransferases for synthesis of polar PIM species and LMs [106]. C35/C50-P-Manp is 
formed by the PPM synthase Ppm1 (Rv2051c) from GDP-Manp and Pol-P [126, 127] (Fig. 
4C). In M. tuberculosis Ppm1 consists of two domains: a C-terminal catalytic domain and a 
N-terminal membrane anchor with 6 transmembrane helices. However, the equivalent 
domains of the M. smegmatis PPM synthase are two distinct, but interacting, proteins [156]. 
The importance of PPM in cell wall synthesis has been highlighted by analysis of a ppm1 
mutant in C. glutamicum that failed to produce PPM, resulting in severe defects in lipoglycan 
biosynthesis. While the mutant could synthesize PIM2 species, all downstream products 
(LM, LAM) were absent, indicating their reliance on the PPM donor [127]. These findings 
were consistent with others showing that amphomycin, an antibiotic specific for PPM-
dependent polymerases, blocked the PIM pathway at the PIM2 or PIM3 stage [125, 128]. The 
product of the Rv3779 gene has also been implicated in PPM synthesis but its role remains 
unclear [157, 158]. 
3.4.1.2. DPA 
DPA is the only known donor of arabinose (Ara) for mycobacterial cell wall synthesis, 
contributing Araf units to arabinogalactan and LAM [106] with concomitant release of Pol-P. 
The Araf portion is derived from the pentose-phosphate pathway [159-161]. 5-
phosphoribose 1-diphosphate is transferred to Dec-P by the Rv3806c gene product [162] and 
the resultant Dec-P-β-D-5-phosphoribose is dephosphorylated to form Dec-P-β-D-ribose. 
Oxidation of the 2’ hydroxyl is followed by a reduction reaction to form DPA. This two-step 
epimerization reaction is catalyzed by the combined activities of DprE1 (Rv3790) and DprE2 
(Rv3791) [163]. Since DPA is the sole donor of Araf residues for mycobacterial cell wall 
synthesis, this pathway is of interest for drug development. Indeed, DprE1 is the target of 
dinitrobenzamide derivatives (DNBs) [164] and a set of nitro-compounds related to DNBs, 
the nitro-benzothiazinones (BTZ), a class of compounds with nanomolar anti-M. tuberculosis 
activities but minimal host-cell toxicity [165-167]. The essential nature of DprE1 in species 
beyond M. tuberculosis [168] reinforces it as a “magic” drug target [169]. The crystal structure 
of M. tuberculosis DprE1 complexed with BTZ inhibitors has been reported very recently, 
revealing the mode of inhibitor binding [170]. 
3.4.2. Carotenoids 
Carotenoids are isoprenoid pigments widely distributed in biology and mostly based on C40-
polyene. Synthesis of these pigments has been poorly studied in mycobacteria but they have 
proven useful for taxonomic and identification purposes. Mycobacterial pigments are 
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generally yellow or orange and most have been confirmed as carotenoids [171]. While 
carotenoid genetics has been best studied in plants, the key enzymes of the pathway have 
been identified in bacteria, including mycobacteria [172-174]. There are two classes of 
carotenoids in bacteria, carotenes and xanthophylls, the latter of which contain oxygen. Both 
classes are composed of eight isoprenoid units with a long central chain of double bonded 
carbons. A consensus pathway for carotenoid biosynthesis in bacteria has been elucidated 
with orthologues of key enzymes identified in several species of mycobacteria [175]. As 
described above for prenol lipids, the carotenoid pathway begins with isopentenyl 
diphosphate and dimethylallyl diphosphate derived from the MEP pathway [176]. Head-to-
tail condensation of these terpenes produces geranylgeranyl pyrophosphate (GGPP) due to 
the activity of GGPP synthase (CrtE). Condensation of two GGPP molecules [177] is 
followed by desaturation to phytoene by phytoene synthase (CrtB). Phytoene desaturase 
(CrtI) converts phytoene to lycoprene followed by cyclization to β-carotene by lycoprene 
cyclase (CrtY) [178]. 
4. Concluding remarks 
Lipid metabolism in mycobacteria and corynebacteria is a highly complex network of 
catabolic and anabolic reactions. While the metabolic pathways and many of the enzymes 
involved have been actively elucidated over the past decade, substantial efforts are still 
needed to draw a comprehensive map of lipid metabolism in these organisms. In particular, 
our understanding of regulatory mechanisms of lipid metabolism is currently at an early 
stage. In addition, there are very few studies describing the interactions between multiple 
metabolic pathways of lipid biosynthesis. One promising approach for the comprehensive 
understanding of lipid metabolism is lipidomics, which is the study of lipid biosynthetic 
and catabolic pathways at a global level [179]. In the past, metabolic pathways have 
generally been examined in isolation without consideration of how different pathways 
might interact with, and influence, one another. Since the plasma membrane is a shared 
platform for most lipid biosynthetic pathways, and some donors are shared between 
different pathways (see above), it seems unlikely that the various pathways are truly 
independent. Recent advances in mass spectrometry (e.g. MALDI-MS, ESI-MS), nuclear 
magnetic resonance spectroscopy and associated computational methods have fuelled the 
development of this field [180]. Members of the Corynebacterineae, with their extensive 
lipid repertoires and complex metabolic pathways, would seem to be ideal targets to assess 
the true potential of lipidomics technologies. Recently, appropriate databases and methods 
for detection and identification of all major lipid classes of M. tuberculosis from a single 
crude extract have been developed [181, 182].  Very recently, a lipidomics profiling platform 
has been reported that uses high-performance liquid chromatography/mass spectrometry to 
resolve more than 12,000 molecules from M. tuberculosis [183]. These exciting advances 
provide a basis for future studies on the regulation of lipid metabolism and may allow, for 
the first time, a true appreciation of the interactive lipid networks of mycobacteria and 
corynebacteria. 
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